136 related articles for article (PubMed ID: 37094652)
1. Efficacy, safety, and treatment patterns of ruxolitinib 1.5% cream in adult atopic dermatitis: A single center retrospective study.
Stefanko NS; Quan VL; Chovatiya R
J Am Acad Dermatol; 2023 Aug; 89(2):415-417. PubMed ID: 37094652
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies.
Papp K; Szepietowski JC; Kircik L; Toth D; Eichenfield LF; Leung DYM; Forman SB; Venturanza ME; Sun K; Kuligowski ME; Simpson EL
J Am Acad Dermatol; 2021 Oct; 85(4):863-872. PubMed ID: 33957195
[TBL] [Abstract][Full Text] [Related]
3. Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies.
Simpson EL; Bissonnette R; Chiesa Fuxench ZC; Kallender H; Sturm D; Ren H; Stein Gold LF
J Dermatolog Treat; 2024 Dec; 35(1):2310633. PubMed ID: 38297490
[No Abstract] [Full Text] [Related]
4. Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies.
Bloudek L; Eichenfield LF; Silverberg JI; Joish VN; Lofland JH; Sun K; Augustin M; Migliaccio-Walle K; Sullivan SD
Am J Clin Dermatol; 2023 Jan; 24(1):109-117. PubMed ID: 36264430
[TBL] [Abstract][Full Text] [Related]
5. Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis.
Hoy SM
Am J Clin Dermatol; 2023 Jan; 24(1):143-151. PubMed ID: 36538235
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies.
Papp K; Szepietowski JC; Kircik L; Toth D; Eichenfield LF; Forman SB; Kuligowski ME; Kallender H; Sun K; Ren H; Simpson EL
J Am Acad Dermatol; 2023 May; 88(5):1008-1016. PubMed ID: 36574595
[TBL] [Abstract][Full Text] [Related]
7. A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis.
Bissonnette R; Call RS; Raoof T; Zhu Z; Yeleswaram S; Gong X; Lee M
Am J Clin Dermatol; 2022 May; 23(3):355-364. PubMed ID: 35368221
[TBL] [Abstract][Full Text] [Related]
8. Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis.
Leung DYM; Paller AS; Zaenglein AL; Tom WL; Ong PY; Venturanza ME; Kuligowski ME; Li Q; Gong X; Lee MS
Ann Allergy Asthma Immunol; 2023 Apr; 130(4):500-507.e3. PubMed ID: 36586583
[TBL] [Abstract][Full Text] [Related]
9. Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year.
Hu W; Thornton M; Livingston RA
Am J Clin Dermatol; 2024 Mar; 25(2):327-332. PubMed ID: 38243107
[TBL] [Abstract][Full Text] [Related]
10. Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis.
Blauvelt A; Kircik L; Papp KA; Simpson EL; Silverberg JI; Kim BS; Kwatra SG; Kuligowski ME; Venturanza ME; Wei S; Szepietowski JC
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):137-146. PubMed ID: 36066323
[TBL] [Abstract][Full Text] [Related]
11. Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies.
Blauvelt A; Szepietowski JC; Papp K; Simpson EL; Silverberg JI; Kim BS; Kwatra SG; Kuligowski ME; Venturanza ME; Wei S; Kircik L
J Am Acad Dermatol; 2023 Mar; 88(3):651-653. PubMed ID: 36113614
[No Abstract] [Full Text] [Related]
12. Ruxolitinib cream for the short-term treatment of mild-moderate atopic dermatitis.
Krajewski PK; Szepietowski JC
Expert Rev Clin Immunol; 2023 Apr; 19(4):349-356. PubMed ID: 36542765
[TBL] [Abstract][Full Text] [Related]
13. Response to Papp et al's "Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies".
Isaq NA; Link JL
J Am Acad Dermatol; 2024 Jan; 90(1):e19-e20. PubMed ID: 37708975
[No Abstract] [Full Text] [Related]
14. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
15. Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream.
Kim BS; Howell MD; Sun K; Papp K; Nasir A; Kuligowski ME;
J Allergy Clin Immunol; 2020 Feb; 145(2):572-582. PubMed ID: 31629805
[TBL] [Abstract][Full Text] [Related]
16. Ruxolitinib (Opzelura) for atopic dermatitis.
Med Lett Drugs Ther; 2022 Jan; 64(1642):12-13. PubMed ID: 35134043
[No Abstract] [Full Text] [Related]
17. Lack of efficacy of topical furfuryl palmitate in pediatric atopic dermatitis: a randomized double-blind study.
Tripodi S; Di Rienzo Businco A; Panetta V; Pingitore G; Volterrani A; Frediani T; Pelosi S; Miceli Sopo S
J Investig Allergol Clin Immunol; 2009; 19(3):204-9. PubMed ID: 19610263
[TBL] [Abstract][Full Text] [Related]
18. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.
Hanifin J; Gupta AK; Rajagopalan R
Br J Dermatol; 2002 Sep; 147(3):528-37. PubMed ID: 12207596
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Moisturizing Creams for the Prevention of Atopic Dermatitis Relapse: A Randomized Double-blind Controlled Multicentre Clinical Trial.
Åkerström U; Reitamo S; Langeland T; Berg M; Rustad L; Korhonen L; Lodén M; Wirén K; Grände M; Skare P; Svensson Å
Acta Derm Venereol; 2015 May; 95(5):587-92. PubMed ID: 25594845
[TBL] [Abstract][Full Text] [Related]
20. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial.
Janmohamed SR; Oranje AP; Devillers AC; Rizopoulos D; van Praag MC; Van Gysel D; Goeteyn M; de Waard-van der Spek FB
J Am Acad Dermatol; 2014 Jun; 70(6):1076-82. PubMed ID: 24698702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
